Mirion Q4 2024 Earnings Report

Mirion reported record revenue, adjusted EBITDA, and EPS in Q4 2024.

Key Takeaways

Mirion achieved a 10.40% YoY revenue increase, reaching $254,300,000, with GAAP net income of $15,900,000. Adjusted EBITDA grew by 14.10% YoY, driven by strong organic growth in the Nuclear & Safety and Medical segments.

Revenue increased by 10.40% YoY to $254,300,000.

GAAP net income improved significantly to $15,900,000 from a $14,500,000 loss last year.

Adjusted EPS rose to $0.17 from $0.15 YoY.

Nuclear & Safety and Medical segments contributed to strong revenue and margin growth.

Total Revenue

$254M

Previous year: $230M

+10.4%

EPS

$0.17

Previous year: $0.15

+13.3%

Operating Margin

11.4%

Previous year: 5.8%

+96.6%

Adjusted EBITDA

$69.6M

Previous year: $61M

+14.1%

Mirion Revenue

Mirion EPS

Forward Guidance

Mirion reaffirmed its 2025 financial guidance, expecting continued revenue growth, margin expansion, and stronger free cash flow.

Positive Outlook

Revenue growth guidance of 4.0% - 6.0%.
Organic revenue growth projected at 5.5% - 7.5%.
Adjusted EBITDA guidance between $215,000,000 and $230,000,000.
Adjusted EPS expected between $0.45 and $0.50.
Company has approximately half of expected 2025 revenue in backlog.

Challenges Ahead

Foreign exchange rate headwind of 190 basis points affecting revenue growth.
Lasers business closure to impact organic revenue growth by 30 basis points.
Foreign exchange rate expected to negatively impact adjusted EBITDA by $6,000,000.
Uncertainty in large order potential of $300,000,000 - $400,000,000.
Ongoing economic risks, including inflation and supply chain challenges.